Adding hyperthermic intraperitoneal chemotherapy (HIPEC) to cytoreductive surgery significantly improved overall survival (OS) in women with platinum-sensitive, recurrent epithelial ovarian carcinoma, ...

HIPEC surgery is a promising treatment option for patients with certain abdominal cancers. Surgical oncologist Erin Ward, MD, discusses which patients would be best candidates for HIPEC, explains why ...

Hyperthermic intraperitoneal chemotherapy has a debated role in advanced gastrointestinal cancers. The data from this randomized study inform that hyperthermic intraperitoneal chemotherapy following ...

Surgical lymph node clearance and pathologic evaluation in gastric cancer. Background: Peritoneal carcinomatosis is a common sign of advanced tumor stage or disease recurrence in patients with gastric ...

HIPEC addition to SCS did not improve progression-free survival in platinum-sensitive recurrent ovarian cancer patients. Both SCS alone and SCS with HIPEC groups exhibited similar safety profiles, ...

Hyperthermic intraperitoneal chemotherapy (HIPEC) provides an important treatment option that can improve survival for some patients with advanced peritoneal cancer. Managing this disease — and ...

Ovarian cancer often goes undetected until it spreads to other areas. In its late stages, it's harder to treat. Now there's an unconventional treatment being used to get rid of it. When her stomach ...

Median progression-free survival (PFS) improved from 23 months with surgery alone to 25 months with the addition of hyperthermic intraperitoneal chemotherapy (HIPEC), a nonsignificant difference. Post ...

Lewis Black was propped up on pillows in his room at Huntsman Cancer Institute, with his wife, Kara, and daughters, Miriam, 14, and Lily, 11, by his side. He was recovering from an 11-hour surgery to ...

Almost every woman with ovarian cancer will have surgery. The kind of surgery depends on your cancer type and stage, and your overall health. Because ovarian cancer has few or no symptoms, about three ...